Psoriasis is a chronic autoimmune condition that causes thick, scaly patches on the skin. It affects roughly 1 in 200 people worldwide, and the number has been climbing steadily over the past three decades. The condition isn’t just cosmetic. The same immune dysfunction that drives visible skin changes also raises the risk of heart disease, diabetes, and joint problems.
What Happens Inside the Skin
In healthy skin, new cells form in the deepest layer and travel to the surface over the course of 40 to 56 days, eventually shedding invisibly. In psoriatic skin, that journey takes just 6 to 8 days. Skin cells pile up faster than the body can shed them, creating the raised, scaly patches the condition is known for.
This rapid cell turnover is driven by a misfiring immune system. Specific white blood cells called T cells infiltrate the skin and behave as though they’re fighting an infection that isn’t there. These T cells trigger a cascade of inflammatory signals that tell skin cells to multiply far faster than normal. Those inflammatory signals also recruit more immune cells to the area, creating a self-sustaining loop: inflammation drives skin cell growth, and the growing skin cells release chemicals that attract more immune cells. This is why psoriasis tends to persist rather than resolve on its own.
Genetics and Triggers
Psoriasis has a strong genetic component. About 25% of people with psoriasis have a family history of the condition. One genetic marker in particular stands out: people who carry a specific immune system gene called HLA-Cw6 tend to develop psoriasis earlier in life, often before age 27. In studies of early-onset psoriasis, up to 85% of patients tested positive for this marker.
Having the genetic predisposition doesn’t guarantee you’ll develop psoriasis, though. Environmental triggers usually set it off. Strep throat is one of the most well-documented triggers, especially in children and young adults. Stress, smoking, heavy alcohol use, and certain medications can also provoke a first episode or worsen existing disease.
One distinctive feature of psoriasis is something called the Koebner phenomenon: new patches can appear at sites of skin injury. A cut, scrape, sunburn, tattoo, or even prolonged pressure on the skin can cause psoriasis to erupt in that exact spot. This is why people with psoriasis sometimes notice new patches along a scratch line or surgical scar.
Types of Psoriasis
Psoriasis takes several forms, and they look quite different from one another.
- Plaque psoriasis is by far the most common type. It appears as raised, reddish patches covered with silvery-white scales, typically on the elbows, knees, scalp, and lower back. The patches have sharp, well-defined borders and tend to appear symmetrically on both sides of the body.
- Guttate psoriasis shows up as small, droplet-shaped spots scattered across the trunk, upper arms and legs, face, and scalp. It often appears suddenly after a streptococcal throat infection and is more common in children and young adults.
- Inverse psoriasis develops in skin folds: the armpits, groin, under the breasts, and between the buttocks. Because moisture and friction in these areas prevent scales from forming, it appears as smooth, bright red, well-defined patches instead.
- Pustular psoriasis produces small pus-filled bumps on an inflamed, reddened base. A localized version affects only the palms and soles. The generalized form is rare but serious, causing widespread pustules along with fever, fatigue, and joint pain.
- Erythrodermic psoriasis is the most severe form, covering 80% or more of the body surface. The skin becomes intensely red and inflamed, and the typical thick plaques give way to widespread peeling. This form requires immediate medical attention.
Beyond the Skin
Psoriasis is not a skin-only disease. The chronic inflammation that drives it circulates throughout the body and raises the risk of several serious conditions.
Heart disease is the most significant concern. People with severe psoriasis have a 53% higher risk of major cardiac events, including heart attack, stroke, and cardiovascular death, even after accounting for traditional risk factors like high blood pressure and cholesterol. Even mild psoriasis carries a measurable increase: a 29% higher risk of heart attack and a 12% higher risk of stroke compared to the general population.
Type 2 diabetes risk also climbs. After controlling for weight, blood pressure, and cholesterol, psoriasis alone raises the risk of developing diabetes by about 14%. For people with severe psoriasis, that figure jumps to 46%.
Psoriatic Arthritis
Up to 30% of people with psoriasis eventually develop psoriatic arthritis, a condition that causes pain, stiffness, and swelling in the joints and in the connective tissue where tendons and ligaments attach to bone. It can affect the fingers, toes, spine, and larger joints like the knees and ankles. An estimated 10 to 15% of psoriasis patients have undiagnosed psoriatic arthritis, partly because symptoms can be subtle early on and there’s no single definitive test for it. Joint stiffness in the morning, swollen fingers or toes, and pain at the back of the heel are common early signs worth paying attention to.
How Psoriasis Is Treated
Treatment follows a stepwise approach based on severity. Mild psoriasis, which covers a relatively small area of the body, is typically managed with creams and ointments applied directly to the skin. Corticosteroid creams are the most commonly prescribed option. Synthetic forms of vitamin D that slow skin cell growth are another staple, used alone or combined with corticosteroids. Milder formulations are used on sensitive areas like the face and skin folds, while stronger versions are reserved for thicker, more stubborn patches on the elbows and knees.
If topical treatments aren’t enough, light therapy is the next step. This involves exposing the skin to controlled doses of ultraviolet light on a regular schedule. It’s considered a first-line treatment for moderate to severe psoriasis and works by slowing the rapid skin cell turnover at the root of the problem.
For moderate to severe cases that don’t respond to creams or light therapy, systemic treatments come into play. These are oral or injected medications that work throughout the body to calm the overactive immune response. Newer biologic therapies target the specific immune pathways involved in psoriasis, blocking the inflammatory signals that drive skin cell overproduction. People with pustular or erythrodermic psoriasis typically need systemic treatment from the start because of the severity and widespread nature of their disease.
Psoriasis is a lifelong condition, but most people can achieve significant clearing with the right treatment approach. Flares and remissions are common, and treatment plans often need adjusting over time as the disease responds differently to therapies or as new options become available.
How Severity Is Measured
Doctors use a scoring system called the Psoriasis Area and Severity Index (PASI) to track the condition over time. It combines the percentage of body surface affected with assessments of redness, thickness, and scaling. Scores range from 0 (completely clear) to a theoretical maximum of 72. A score under 10 is classified as mild psoriasis, while anything above 10 indicates moderate to severe disease. This scoring matters most when determining whether you qualify for stronger treatments, since many systemic and biologic therapies are reserved for patients who meet specific severity thresholds.